Nyxoah SA Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
NYXH
Nyxoah SACVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a combined beneficial ownership of 9.9% in Nyxoah SA's ordinary shares, primarily through convertible notes.
NASDAQ
NYXH
Nyxoah SASCHEDULE: ResMed Inc. Discloses Nyxoah SA Stake
ResMed Inc. has filed a Schedule 13G, reporting beneficial ownership of 1,943,828 ordinary shares in Nyxoah SA, representing 1.95% of the outstanding shares.
NASDAQ
NYXH
Nyxoah SACVI Investments, managed by Heights Capital Management, disclosed a 9.9% beneficial ownership stake in Nyxoah SA, primarily through convertible notes.
NASDAQ
NYXH
Nyxoah SASCHEDULE 13G/A: Vestal Point Capital Discloses 3.7% Stake in Nyxoah SA
Vestal Point Capital, LP and Ryan Wilder have reported a 3.7% beneficial ownership stake in Nyxoah SA, holding 1,402,002 ordinary shares.
NASDAQ
NYXH
Nyxoah SASCHEDULE 13G/A: Vestal Point Capital Discloses 6.2% Passive Stake in Nyxoah SA
Vestal Point Capital, LP and its Chief Investment Officer, Ryan Wilder, have disclosed a passive 6.2% beneficial ownership stake in Nyxoah SA, holding 2,318,954 ordinary shares.
NASDAQ
NYXH
Nyxoah SAVestal Point Capital, LP and Ryan Wilder have jointly disclosed a 7.8% beneficial ownership stake in Nyxoah SA, holding 2,924,216 ordinary shares as of December 31, 2024.